SSC-SYSTEMIC SCLEROSIS
Clinical trials for SSC-SYSTEMIC SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new SSC-SYSTEMIC SCLEROSIS trials appear
Sign up with your email to follow new studies for SSC-SYSTEMIC SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for slowing deadly lung scarring in scleroderma patients
Disease control Recruiting nowThis study looks back at the medical records of 35 people with scleroderma who have developed lung scarring. It compares two treatment approaches: a standard two-drug combination versus that same combination plus an extra anti-scarring drug. The goal is to see if adding the third…
Matched conditions: SSC-SYSTEMIC SCLEROSIS
Sponsor: University of Patras • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
First-of-its-Kind cell therapy trial targets Hard-to-Treat scleroderma
Disease control Recruiting nowThis is an early, exploratory study to test the safety and initial effects of a new cell therapy called CT1195E in people with severe, worsening systemic sclerosis (scleroderma). The therapy involves collecting and genetically modifying a patient's own immune cells (CAR-T cells) …
Matched conditions: SSC-SYSTEMIC SCLEROSIS
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
Scientists test 'Off-the-Shelf' cell therapy to reset immune system in devastating autoimmune diseases
Disease control Recruiting nowThis early-phase study is testing a new type of cell therapy called QT-019C for people with severe autoimmune diseases that have not improved with standard treatments. The therapy uses donated, 'universal' immune cells engineered to target and remove harmful immune cells. The mai…
Matched conditions: SSC-SYSTEMIC SCLEROSIS
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
New drug tested for patients with severe autoimmune diseases who have run out of options
Disease control Recruiting nowThis is a very early study to check the safety and initial effects of an experimental drug called CC312. It is for adults with severe, relapsed forms of lupus, myositis, or scleroderma that have not improved with standard treatments. The main goal is to find a safe dose and see h…
Matched conditions: SSC-SYSTEMIC SCLEROSIS
Phase: EARLY_PHASE1 • Sponsor: CytoCares Inc • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC